Oxford Science Enterprises
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Ascension secures £1.7m in funding from UKI2S and Innovate UK to tap geothermal critical mineral reserves
Ascension develops technology to recover critical minerals from underground geothermal systems. It enables extraction from volcanic rock deposits without surface mining, reducing environmental impact and reliance on concentrated supply chains.
Archangel Lightworks raises £10m Series A led by Santander Alternative Investments for space-to-ground laser communications
Archangel Lightworks builds laser communication systems that connect space-based networks with infrastructure on the ground. Its deployable optical ground station enables high-speed, secure data transfer for applications such as connectivity, monitoring, and communications.
Stateful Robotics raises a £3.6m pre-seed led by Amadeus Capital Partners and Oxford Science Enterprises to help robots operate reliably in the real world
Stateful Robotics develops software that helps robots plan and operate reliably in real-world environments. It provides a system that tracks past activity and performance so robots can adapt to changing conditions and complete tasks over time.
Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs
Allos AI applies causal AI to reformulate complex generic drugs, improving delivery, tolerability and predictability while reducing development uncertainty.
Scripta Therapeutics raises £9m seed led by Oxford Science Enterprises and Apollo Health Ventures to upend conventional drug discovery
Scripta Therapeutics applies AI and experimental biology to map disease-driving transcription networks, aiming to identify new drug targets for neurodegenerative and complex conditions.
Wild Bio secures £45m Series A led by the Ellison Institute of Technology to boost crop resilience by learning from wild species
Wild Bio applies AI and precision breeding to crop genetics, using insights from wild plant species to develop climate-resilient, higher-yield crop varieties for commercial agriculture.
Kneu Health raises £4m seed round co-led by Oxford Science Enterprises and Cedars-Sinai to scale precision neurology platform
Kneu Health develops a precision neurology platform that uses smartphone-based data and clinically trained AI models to monitor Parkinson’s and dementia continuously, supporting earlier intervention and more proactive neurological care.
Ultromics raises £40m Series C led by L&G, Allegis Capital and Lightrock to expand AI heart failure diagnostics in the US
Ultromics develops AI software that analyses echocardiograms to help clinicians detect hard-to-diagnose heart failure conditions earlier, without requiring new hardware or changes to existing clinical workflows.
NavLive raises £4m seed round led by OSE to launch real-time AI scanner for architecture and construction
NavLive develops a handheld AI-powered scanning device that creates real-time, high-precision building surveys, enabling architects and construction teams to generate instant 2D and 3D models on site.
Neu Health raises £1.6m from Cedars-Sinai and Oxford Science Enterprises to expand neurology care platform
Neu Health provides a digital care platform for neurological conditions, enabling continuous patient monitoring and personalised care plans to support people living with Parkinson’s and dementia.
More venture news
- 16 Apr 2026
OpenmooveOpenmoove lands £700k in funding led by Development Bank of Wales to streamline property transaction workflows
EquityProperty - 15 Apr 2026
The Little LoopThe Little Loop secures £750k in funding from The FSE Group for B2B2C clothing trade-in and resale platform
EquityCommerce - 15 Apr 2026
AscensionAscension secures £1.7m in funding from UKI2S and Innovate UK to tap geothermal critical mineral reserves
EquityIndustrial
